| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| Asante Solutions (PUMP) | Leerink Partners/ Cowen and Company | $45.00 | n.a. | |||
| Ascendis Pharma A/S (ASND) | BofA Merrill Lynch/ Leerink Partners | $86.25 | n.a. | |||
| InfraREIT (HIFR) | BofA Merrill Lynch/ Citigroup | $400.00 | n.a. | |||
| Patriot National (PN) | UBS Investment Bank/ BMO Capital Markets/ SunTrust Robinson Humphrey | $100.00 | n.a. | |||
| Reverse Mortgage Investment Trust (RMIT) | FBR | $100.00 | n.a. | |||
| Summit Materials (SUM) | Citigroup/ Goldman Sachs/ BofA Merrill Lynch/ Barclays/ Deutsche Bank Securities/ RBC Capital Markets | $100.00 | n.a. | |||
| Yulong Eco-Materials (TBA) | Cuttone/ Axiom Capital Management | $10.00 | n.a. | |||
| n.a. (not available) | ||||||
| Postponed | ||||||
| None | ||||||
| Withdrawn | ||||||
| None | ||||||
| New Terms | ||||||
| Juno Therapeutics (JUNO) | Morgan Stanley/ J.P. Morgan/ Goldman Sachs | 9.25 | $21.00 | $23.00 | $203.50 | 4-Stars |
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Week of Dec. 15, 2014 | Manager(s) | Offered | Raised | Price | 12/19/14 | Change |
| Juno Therapeutics (JUNO) | Morgan Stanley/ J.P. Morgan/ Goldman Sachs | 11.02 | $264.55 | $24.00 | $35.00 | 45.83% |
| On Deck Capital (ONDK) | Morgan Stanley/ BofA Merrill Lynch/ J.P. Morgan/ Deutsche Bank Securities/ Jefferies | 10.00 | $200.00 | $20.00 | $24.15 | 20.75% |
| Bellicum Pharmaceuticals (BLCM) | Jefferies/ Citigroup/ Piper Jaffray | 7.35 | $139.65 | $19.00 | $19.77 | 4.05% |
| Rice Midstream Partners LP (RMP) | Barclays | 25.00 | $412.50 | $16.50 | $17.15 | 3.94% |
| Medovex (MDVXU) (u) | Laidlaw & Company (UK) Ltd. | 1.39 | $8.01 | $5.75 | $5.85 | 1.74% |
| (u) Unit offering | ||||||
